Our results showed up-regulation of Sestrins, β-regulatory AMPK-subunits, and down-regulation of regulatory components of the translational machinery (RPS6KB2/p70S6K-beta, RPS6), supporting an inhibitory effect of p53-re-activation on PI3K/mTOR pathway in lymphomas. The gene discussed is TP53; the disease is lymphoma.